Company Profile

Sourcing Inquiry Logo Biospective

Biospective

Regions
North America
Countries
Canada
Size
n.e.
Specialty
Biopharmaceuticals
Service category
Pre-clinical development and testing, pre-clinical CRO, Clinical development and testing, clinical CRO
Content posted and uploaded by users. Want to add your company?
Your company? Get access to this profile.

Summary

Biospecitve have developed sophisticated, integrated multi-modality platforms to maximize the sensitivity for detection of subtle structural, functional, and molecular changes in response to treatment for a comprehensive understanding of therapeutic efficacy.  Our diverse range of services provides our pharmaceutical and biotechnology sponsors with an unparalleled ability to assess novel therapeutic agents in a comprehensive fashion.

 

We offers pathology services including a wide range of histology & immunohistochemistry (IHC) stains in multiple species. We have developed a state-of-the art technology to provide an efficient and accurate IHC marker quantification facilitating the validation of novel disease-modifying therapeutic agents . Conventional quantitative IHC analysis relies on manual or semi-automated segmentation of a few representative, high-power fields.  This labor-intensive process is prone to operator variabilitiy and low sampling, thereby introducing unwanted bias. In contrast, Biospective employs its fully-automated, unbiased, and high-throughput technology to accurately quantify IHC markers. 

 

Biospective utilizes a broad range of imaging modalities to assess the therapeutic potential of novel disease-modifying agents in rodent. We have developed state-of-the-art software to accurately co-register in vivo MRI and 3D quantitative neuropathology measures.  Biospective adheres to internationally-accepted practices to ensure the highest possible quality, integrity, and reliability of our studies. Our pre-clinical studies are conducted in the spirit of GLP and clinical studies follow ICH GCP principles.

Biospective performs advanced image processing in human for a broad range of imaging modalities, namely, PET, structural MRI, and functional MRI imaging studies.  Only Biospective bridges the gap between pre-clinical studies and clinical trials. Our expert team of scientists works closely with our clients to design mechanism-of-action and efficacy studies that increase the chances of success. 

Pictures of this company

You might also be interested in

Sourcing this company's services?

Send inquiry anonymously »

Or add this Company to
Sourcing cart